Pembrolizumab SCLC Indication Withdrawn in US Pembrolizumab SCLC Indication Withdrawn in US

The small cell lung cancer (SCLC) indication had been granted an accelerated approval, but a subsequent confirmatory study showed no survival benefit.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news